(Q59595133)
Statements
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist (English)
F Labrie
A Dupont
A Belanger
1 October 1987
scientific article published on 01 October 1987